MedPath
HSA Product

PLASMA-LYTE A INJECTION

Product approved by Health Sciences Authority (SG)

Basic Information

PLASMA-LYTE A INJECTION

INJECTION

Regulatory Information

SIN06523P

August 19, 1991

Prescription Only

Therapeutic

INTRAVENOUS

August 10, 2023

May 30, 2025

XB05BB01

Company Information

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER HEALTHCARE (ASIA) PTE LTD

Active Ingredients

MAGNESIUM CHLORIDE

Strength: 30 mg/100 ml

POTASSIUM CHLORIDE

Strength: 37 mg/100 ml

SODIUM CHLORIDE

Strength: 526 mg/100 ml

SODIUM GLUCONATE

Strength: 502 mg/100 ml

SODIUM ACETATE TRIHYDRATE

Strength: 368 mg/100 ml

Detailed Information

Contraindications

**CONTRAINDICATIONS** PLASMA-LYTE A Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) is contraindicated in patients with a known hypersensitivity to the product. See **WARNINGS** – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_.

Indication Information

**INDICATIONS AND USAGE** PLASMA-LYTE A Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) is indicated as a source of water and electrolytes or as an alkalinizing agent.

© Copyright 2025. All Rights Reserved by MedPath